Guardant Health
GH
$25.36
Share price
-3.35%
Change (1 day)
-14.09%
Change (1 year)
Categories
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.
P/S ratio for Guardant Health (GH)
P/S ratio as of May 2024 (TTM): 5.69
According to Guardant Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.69372. At the end of 2023 the company had a P/S ratio of 5.82.
P/S ratio history for Guardant Health from 2018 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 5.82 | -6.07% |
| 2022 | 6.20 | -77.22% |
| 2021 | 27.2 | -39.44% |
| 2020 | 44.9 | 31.28% |
| 2019 | 34.2 | -3.75% |
| 2018 | 35.6 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Neogen NEOG | 3.13 | -45.10% | 🇺🇸 USA |
 Natera NTRA | 12.3 | 116.17% | 🇺🇸 USA |